B. Metzler seel. Sohn & Co’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
VCM
VPM
B. Metzler seel. Sohn & Co's BIIB Position: Q1 2026 in Review
B. Metzler seel. Sohn & Co reduced its Biogen (BIIB) stake by 0.82% in Q1 2026, selling an estimated $45.3K and leaving 29,725 shares worth $5.45M. The position accounts for 0.05% of the portfolio, ranked #205.
B. Metzler seel. Sohn & Co first reported a position in BIIB in Q4 2020 and has held it in 22 quarters since. 1,009 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- B. Metzler seel. Sohn & Co held 29,725 shares of Biogen worth $5.45M as of Q1 2026.
- B. Metzler seel. Sohn & Co sold 246 Biogen shares in Q1 2026, an estimated $45.3K.
- Biogen made up 0.05% of B. Metzler seel. Sohn & Co's portfolio in Q1 2026, its #205 holding.
- B. Metzler seel. Sohn & Co first reported a position in Biogen in Q4 2020 and has held it in 22 quarters since.
- 1,009 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on B. Metzler seel. Sohn & Co's 13F filing for Q1 2026, filed 8 May 2026.